The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 26, 2023
Filed:
Apr. 05, 2021
Applicants:
Regents of the University of Minnesota, Minneapolis, MN (US);
Emory University, Atlanta, GA (US);
Inventors:
Zhengqiang Wang, Minneapolis, MN (US);
Stefanos G. Sarafianos, Atlanta, GA (US);
Assignees:
REGENTS OF THE UNIVERSITY OF MINNESOTA, Minneapolis, MN (US);
EMORY UNIVERSITY, Atlanta, GA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 239/96 (2006.01); C07D 239/54 (2006.01); A61K 31/513 (2006.01); A61K 31/495 (2006.01); A61K 31/4439 (2006.01); A61K 31/4184 (2006.01); A61K 31/4178 (2006.01); A61K 31/51 (2006.01); C07D 209/34 (2006.01); C07D 235/02 (2006.01); C07D 241/08 (2006.01); A61P 31/18 (2006.01); A61K 31/517 (2006.01); A61K 31/405 (2006.01); C07C 233/88 (2006.01); A61K 31/167 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); A61K 31/167 (2013.01); A61K 31/405 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/4439 (2013.01); A61K 31/495 (2013.01); A61K 31/513 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2018.01); C07C 233/88 (2013.01); C07D 209/34 (2013.01); C07D 235/02 (2013.01); C07D 239/54 (2013.01); C07D 239/96 (2013.01); C07D 241/08 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01);
Abstract
The invention provides a compound of formula I, formula II, or formula III: or a salt thereof, wherein R-Rhave any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as HIV-1 CA-targeting molecules and as antiviral agents.